Psychemedics Corp. (NASDAQ:PMD) VP James V. Dyke sold 10,000 shares of the business’s stock in a transaction dated Tuesday, November 15th. The shares were sold at an average price of $23.56, for a total value of $235,600.00. Following the completion of the sale, the vice president now directly owns 37,654 shares of the company’s stock, valued at $887,128.24. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Shares of Psychemedics Corp. (NASDAQ:PMD) traded up 1.72% during mid-day trading on Wednesday, reaching $24.18. The company had a trading volume of 98,704 shares. The firm has a 50-day moving average of $21.00 and a 200-day moving average of $17.66. Psychemedics Corp. has a 12-month low of $7.76 and a 12-month high of $25.50. The company has a market capitalization of $132.02 million, a P/E ratio of 29.45 and a beta of 0.85.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 17th. Stockholders of record on Monday, November 7th will be paid a dividend of $0.15 per share. The ex-dividend date is Thursday, November 3rd. This represents a $0.60 dividend on an annualized basis and a dividend yield of 2.52%. Psychemedics Corp.’s dividend payout ratio (DPR) is currently 73.17%.

About Psychemedics Corp.

Psychemedics Corporation (Psychemedics) provides hair testing for drugs of abuse, utilizing a hair analysis method involving digestion of hair, enzyme immunoassay (EIA) technology and confirmation by mass spectrometry to analyze human hair to detect abused substances. The Company operates in drug testing services segment.

5 Day Chart for NASDAQ:PMD

Receive News & Stock Ratings for Psychemedics Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Psychemedics Corp. and related stocks with our FREE daily email newsletter.